GovChime
IDVOther than small business

BOA (single-award IDV) 75N95018G00019SRI INTERNATIONAL

Overview

Award facts

Obligated on orders under this IDV
$5.28M
$5,280,914 across 6 orders
Period of performance
From Sep 7, 2018
Modifications
10
Latest action Jul 17, 2024
Contract type
BOA (single-award IDV)
PIID 75N95018G00019

Description of requirement

IGF::OT::IGF PURPOSE TO AWARD THE CONTRACT FOR TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS, PERIOD OF PERFORMANCE: 09/07/2018- 09/06/2023. NIDA REF. NO. N01DA-18-8939

Dates and value

Award date
Signed on Sep 7, 2018
Ordering period ends
Sep 6, 2023
Ceiling
Ceiling (single-award vehicle): $9,750,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 17, 2024. View on USAspending · Recipient on SAM.gov

Recipient

LocationMENLO PARK, CA
UEISRG2J1WS9X63
CAGE code03652
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companySRI INTERNATIONAL

Business types and certifications

Nonprofit organizationTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA

Classification and competition

Classification

Competition

Set-aside
Not reported
Contract pricing
Order dependent (IDV allows pricing arrangement to be determined separately for each order)1

Solicitation and notices

Solicitation ID
NIHDA201800011
Notices

Contract details

Major program
Toxicological evaluations of potential medications
Cost Accounting Standards clause
Not applicable exempt from CASX
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 7, 2018
Latest action
Jul 17, 2024 — Other administrative actionModification P00010; administrative: no change in scope or value
Latest substantive action
Oct 19, 2021 — Change orderModification P00005
Actions by type
  • Base award1
  • Other administrative action9
  • Change order1
11 actions recorded, Sep 7, 2018 to Jul 17, 2024; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Synopsized publicly (SAM.gov / FedBizOpps)
Yes
A-76 (FAIR Act) action
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA

Structure

Award or IDV
IDV
IDV type
BOAD
Multiple or single award
Single awardS
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
11

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N950